BridgeBio Pharma, Inc. (CIK 1743881) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-10-16). Recent activity: Buy BBOT (784,720 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-16 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Insider | Buy | 784,720 | $0 |
Source: SEC Form 4 filings · as of 2025-10-16